Bank of America’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bank of America’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-110,000	Closed	-$1.51M	–	7617
2016 Q3	$1.51M	Buy	+110,000	New	+$1.1M	﹤0.01%	3872
2015 Q2	–	Sell	-286,700	Closed	-$2.36M	–	7573
2015 Q1	$2.36M	Buy	286,700 +263,600	+1,141%	+$1.95M	﹤0.01%	3087
2014 Q4	$159K	Sell	23,100 -88,700	-79%	-$555K	﹤0.01%	5544
2014 Q3	$604K	Buy	111,800 +82,300	+279%	+$481K	﹤0.01%	4414
2014 Q2	$188K	Sell	29,500 -82,700	-74%	-$569K	﹤0.01%	5625
2014 Q1	$904K	Buy	112,200 +20,600	+22%	+$160K	﹤0.01%	4005
2013 Q4	$625K	Buy	91,600 +80,800	+748%	+$436K	﹤0.01%	4559
2013 Q3	$199K	Sell	10,800 -27,500	-72%	-$534K	﹤0.01%	5454
2013 Q2	$670K	Buy	+38,300	New	+$679K	﹤0.01%	4458

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Bank of America's ARIA Position: Q1 2017 in Review

Bank of America sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 67,923 shares — an estimated $846K sold.

Bank of America first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $5.5M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Bank of America reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Bank of America sold 67,923 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $846K.
Bank of America first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Bank of America's Ariad Pharmaceuticals Inc position peaked at $5.5M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Bank of America's 13F filing for Q1 2017, filed 15 May 2017.